MRI distance measures as a predictor of subsequent clinical status during the preclinical phase of Alzheimer's disease and related disorders

Authors

• Xinyi Zhang, Johns Hopkins University
• John C Morris, Washington University School of Medicine in St. Louis
• Tammie L S Benzinger, Washington University School of Medicine in St. Louis
• et al.

Journal

Human brain mapping

Publication Date

4-15-2025

Volume

46

Issue

6

First Page

e70205

Document Type

Open Access Publication

DOI

10.1002/hbm.70205

Rights and Permissions

Zhang, X., Caffo, B.S., Soldan, A., Pettigrew, C., Guray, E., Davatzikos, C., Morris, J.C., Benzinger, T.L.S., Johnson, S.C., Masters, C.L., Fripp, J., Resnick, S.M., Bilgel, M., Kukull, W.A., Albert, M.S. and Wang, Z. (2025), MRI Distance Measures as a Predictor of Subsequent Clinical Status During the Preclinical Phase of Alzheimer's Disease and Related Disorders. Hum Brain Mapp, 46: e70205. https://doi.org/10.1002/hbm.70205 © 2025 The Author(s). Human Brain Mapping published by Wiley Periodicals LLC. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Recommended Citation

Zhang, Xinyi; Morris, John C; Benzinger, Tammie L S; and et al., "MRI distance measures as a predictor of subsequent clinical status during the preclinical phase of Alzheimer's disease and related disorders." Human brain mapping. 46, 6. e70205 (2025).
https://digitalcommons.wustl.edu/oa_4/7065

Department

ICTS (Institute of Clinical and Translational Sciences)